Results 1 to 10 of about 687 (166)
Journal of the Nepal Medical Association, 2021 Alopecia universalis is an uncommon form of alopecia areata involving hair loss over the entire scalp and body. This condition is difficult to treat and sustain the growth of hair for longer duration.
Manish Bhakta Pradhan +2 more
exaly +5 more sources
Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis [PDF]
Case Reports in Dermatology, 2013 Alopecia areata and vitiligo are autoimmune diseases, both associated with multiple autoimmune comorbidities. Many studies show colocalization of these diseases at the same anatomical site.
Hassan Riad +6 more
doaj +6 more sources
Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity—Report of a Case and Review of the Literature [PDF]
Frontiers in Neurology, 2017 Secondary autoimmunity is the most frequent adverse event occurring in almost every other alemtuzumab-treated multiple sclerosis patient. We report a case of a patient with relapsing-remitting multiple sclerosis who reported smooth, circular areas of ...
Julian Zimmermann, Marcus Müller
exaly +4 more sources
Hair regrowth and maintenance in alopecia universalis patient treated with nonablative Er:YAG laser
Clinical Case Reports (discontinued), 2021 Hair regrowth with no adverse effects following nonablative 2940‐nm Er:YAG laser treatment in alopecia universalis patient resulted in high patient satisfaction and compliance. As the main challenge in alopecia universalis is maintenance of regrown hair,
Iva Talaber
exaly +2 more sources
Schizophrenia in a case of alopecia universalis
Annals of Indian Psychiatry, 2017 Alopecia universalis is characterized by total loss of hair from all over the body such as the scalp, eyebrows, and limbs. Alopecia areata has been known to coexist with psychiatric disorders such as anxiety disorders and depression, although reports ...
Deepa Sangolkar +4 more
doaj +2 more sources
Successful treatment of alopecia universalis with abrocitinib: a case report [PDF]
Journal of Dermatological Treatment, 2023 Abrocitinib, a highly selective inhibitor of Janus kinase 1 (JAK1), has been approved for the treatment of moderate-to-severe atopic dermatitis (AD).
Jie- Zhang, Ya-Gang Zuo
doaj +2 more sources
Alopecia Universalis Successfully Treated With Adalimumab [PDF]
JAMA Dermatology, 2014 IMPORTANCE Alopecia universalis is an uncommon form of alopecia areata (AA) involving hair loss over the entire scalp and body and is often difficult to treat. Tumor necrosis factor (TNF)inhibitors have been largely unsuccessful in treating AA and have been reported to induce or worsen AA in patients.We report herein a case of alopecia universalis ...
Loren Gorcey +2 more
openalex +4 more sources
A Case of Hypogonadism Presented with Alopecia Universalis [PDF]
Balkan Medical Journal, 2013 et al. The effects of gonadotropin treatment on the immu- nological features of male patients with idiopathic hypogo- nadotropic hypogonadism. J Clin Endocrinol Metab 2000;85: 66-70. [CrossRef]
Gökhan Celbek +3 more
openalex +6 more sources
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis [PDF]
Case Reports in Dermatology, 2016 Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes surround the basis of the follicles, inducing loss of pigmented terminal hair and subsequently inhibit further hair growth.
Florian Anzengruber +5 more
doaj +6 more sources
Journal of Allergy and Clinical Immunology: GlobalA 29-year-old male patient had severe atopic dermatitis (AD) and alopecia universalis (AU) that could not be controlled by using classic therapy. He started taking upadacitinib and achieved an excellent response for both his AD and AU. Thus, upadacitinib
Mara Giavina-Bianchi, MD, PhD +1 more
doaj +2 more sources